RESEARCHGRADELABTESTED

AP / METABOLIC10MG

01PRODUCT DOSSIER

TIRZEPATIDE

METABOLICRESEARCH

Dual GIP and GLP-1 receptor agonist peptide used in metabolic research.

$149.00AUD

OUT OF STOCK

STRENGTH

QUANTITY

FORMATResearch Compound

DOCUMENTATIONPRODUCT COA

STORAGESTORE AT 2°C–8°C

DISPATCHAUSTRALIA-WIDE

02ABOUT THIS COMPOUND

WHAT IS TIRZEPATIDE?

Tirzepatide is a 39-amino-acid synthetic peptide derived from the GIP sequence and engineered for dual GIP and GLP-1 receptor activity. It is studied in models of glucose regulation, insulin signalling, appetite pathways and lipid metabolism.

03RESEARCH APPLICATIONS

Dual GIP / GLP-1 receptor activity
Insulin-signalling research
Glucose-homeostasis models
Appetite-regulation pathways
Long-acting peptide design

04RESEARCH PROFILE

Dual incretin-receptor profile
39-amino-acid synthetic peptide
Well-characterised metabolic mechanism
Acylated long-acting design
Multiple strengths available

RESEARCH USE ONLY

NOT FOR HUMAN CONSUMPTION / NOT FOR DIAGNOSTIC OR THERAPEUTIC USE

PEPTIDE CLASS

Dual GIP / GLP-1 receptor agonist

CHAIN LENGTH

39 amino acids

MOLECULAR FORMULA

C225H348N48O68

FORMAT

Lyophilised powder

APPEARANCE

White lyophilised powder

PURITY

≥ 98%

AVAILABLE

10MG / 20MG / 30MG / 40MG

RELATED COMPOUNDS

VIEW ALL PRODUCTS →